Assessing the Accuracy of Seismofit® as an Estimate of VO2 Peak in Patients With Hepato-pancreato-biliary, Colorectal, and Gastro-oesophageal Cancer

NCT05831488 · clinicaltrials.gov ↗

UNKNOWN

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Hepato-Biliary Carcinoma in Situ Nos
Pancreatic Cancer
Colorectal Cancer
Gastric Cancer
Oesophageal Cancer

Interventions

OTHER: Non-Interventional

Sponsor

Royal Marsden NHS Foundation Trust